The table below shows CYTOKINETICS INC's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
-$510.01M
-$395.89M
-$414.33M
-$299.52M
-$142.52M
$8.94M
Capital expenditure
$24.81M
$3.91M
$1.42M
$11.34M
$48.87M
$11.05M
Investing cash flow
$16.67M
-$553.10M
$239.25M
-$262.13M
-$147.78M
-$196.51M
Dividends paid
-
-
-
-
-
CYTK operating cash flow (10-K history)
CYTOKINETICS INC reported operating cash flow of -$510.01M for fiscal year 2025. That is down 28.8% from -$395.89M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$7.72M (FY 2013) to -$510.01M. Figures come from the company's audited annual reports as filed with the SEC.
